Wed, Aug 27, 2014, 7:20 AM EDT - U.S. Markets open in 2 hrs 10 mins

Recent

% | $
Quotes you view appear here for quick access.

Diamond Foods, Inc. (DMND) Message Board

rogerxavier2 552 posts  |  Last Activity: 8 hours ago Member since: Jan 8, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • rogerxavier2 rogerxavier2 8 hours ago Flag

    " And a Seeking Alpha hit job is NOT a good starting point for understanding a company or its products."
    I was aware of Isolagen and its fraudulent practices long before the Ampio reverse merger. I see that Flibroell is soon to move to the Nasdaq without some of the original stock stuffers.
    Part of the crew didn't want to wait this long to start raking it in and engineered a fast track path via reverse merger?

    The frozen drug tale looks like an attempt to throw away the STEP data and string out investor HOPE into the new year. It looks like the management is slapping you in the face with their data sheets and demanding more money.

    IMO they won't go BK until the company is wrung out and devoid of cash.

  • rogerxavier2 rogerxavier2 8 hours ago Flag

    " This is not a one site study - just to start - and that is not the CRO."
    Dr Vo's office is the only site listed on the clinical trial.
    Don't the CRO's do the recruitment if the sponsor does not?
    The recruiter is dreamteamclinial.

    Try to reconcile these:.
    15 degrees Celsius is ~ 59 degrees Fahrenheit.
    The test substance would have had to have been in a heated vehicle/warehouse for January delivery yet many of the vials were frozen?

    From Macaluso's letter of Aug 21:
    "The drug temperature specifications were set because AmpionTM may lose potency if it is exposed to temperatures approaching freezing." How close to freezing is 59F? Kinda far. Apparently the 'frozen' part of the story wasn't really necessary.

    "our CRO discovered much of the drug product received at the clinical sites had been below the temperature requirement and may have been frozen for some period of time." received at the clinical siteS
    From the letter of Aug 25:
    "Only one clinical trial site reported any frozen product and that shipment was replaced immediately upon notice. "

    Aug 21:
    " During the review of all documentation following the unblinding of the Study, our CRO determined that there were multiple instances where the in-package temperature monitor fell significantly below the 15 degrees C minimum required."
    Aug 25:
    " Ampio was made fully aware of the temperature excursions at the time of data lock,"
    "The analysis of the Data has still not been made available to Ampio, although, as can be imagined we are anxious to view it."
    The data was unblinded, we have have that data but not the analysis? Wait it wasn't at unblinding it was when we stopped collecting further data.

    By the way we are going to void protocol and add in data from an ongoing study. STEP took only 39 days to fully enroll 500 people. It will take several months to finish enrolling in the on going study, It took six months to complete the Step study. The ongoing study will be complete and available for BLA use in Q1,2015.

  • rogerxavier2 rogerxavier2 12 hours ago Flag

    "Roger, The simple fact is this company has more clinical history and track record than STEP."

    As do many pharmaceuticals entered for approval by FDA, however the phase 3 or later trials carry the burden of proof.

    AMPE's stock manipulation track record is more exciting than it treatments'.

  • Reply to

    Grindle-Rogerxavier battle

    by arikofunit101 13 hours ago
    rogerxavier2 rogerxavier2 12 hours ago Flag

    Did you bother to read his post?
    Mr. Wilson found him.

    Company is so obscure it doesn't even have a website.
    Yet it is allowed to be a CRO for Ampio.

    "David Wilson
    August 26, 2014 at 12:54 am
    If anyone had simply took the time to address or substantiate what was written here it would’ve been a completely different story. I am the CEO for Dream Team and everything that is written about my company and my investigators couldn’t be farther more the truth. Logic would tell you that no one single investigative site could possibly conduct a 500 patient clinical study. There were 30+ clinical
    sites involved and we only accounted for 28 of those randomized. As for the temp excursions, our IP was continually monitored and we had no such fluctuations.

    [@David - Agreed that one site makes little sense. That is what made the story so strange, and worthy of investigation. If there were indeed 30+ clinical sites involved, why do the records at Clinicaltrials.gov only show one site, yours? - Editor]"

    google
    buyersstrike plus AMPE

  • Reply to

    Grindle-Rogerxavier battle

    by arikofunit101 13 hours ago
    rogerxavier2 rogerxavier2 13 hours ago Flag

    Facility
    Status
    Contact
    Investigator
    Quang Vo, MD
    Anaheim California 92801 United States
    Recruiting
    Last Name: Michelle Cook
    Phone: 714-269-6161
    Email: mcookdreamteamcliniccom
    Last Name: Quang Vo, MD
    Role: Principal Investigator

  • Reply to

    Grindle-Rogerxavier battle

    by arikofunit101 13 hours ago
    rogerxavier2 rogerxavier2 13 hours ago Flag

    "As of an hour-and-a-half ago Roger is still claiming Dream Team/Dr. Vo was the CRO for the STEP study "

    Had you bothered to read grindle's post you would have noticed that Mr. Wilson the CEO of dreamteamclinic confirmed their position as CRO. Dr. Vo is the investigator.

  • rogerxavier2 rogerxavier2 13 hours ago Flag

    " I think the number is 807 or more here in America and a large number in Australia at 102,"

    The enrollment for the STEP study was closed in Feb. @014 the actuall number enrolled was not in the press release but the most it could have been was 500.

    Your fellow MB posters are correct. Your information is not worth the electrons taken to make it readable.
    Ignore.

  • rogerxavier2 rogerxavier2 15 hours ago Flag

    " Logic would tell you that no one single investigative site could possibly conduct a 500 patient clinical study"
    Exactly.
    "There were 30+ clinical sites involved and we only accounted for 28 of those randomized." One assumes that David means 28 patients. Notice that David cannot account for the claimed other sites.
    As the CRO, DreamTeamMedical is responsible for ALL of the sites.A competent CEO would know this.
    Maybe he should have asked Dr. Vo who was apparently very busy hopping from one site to another with syringes locked and loaded.

    The CRO is responsible for ALL of the IP monitoring as well, not just for one site, if in fact there were more than 28 patients signed on.
    "As for the temp excursions, our IP was continually monitored and we had no such fluctuations." States the CEO of the CRO.
    If there were NO "Temperature Excursions" why would the sponsor issue a PR stating that there were.

    Either the Sponsor or their designated surrogate is woefully incompetent.
    Perceptual disconnect.

    Thanks for the copy/paste grindle.

  • rogerxavier2 rogerxavier2 15 hours ago Flag

    "It is comical that the basher group doesn't spend any time over at Kodaks mb bashing their forward momentum with uni pixel"

    It's even more comical that you profess to believe that there is forward momentum with UN eXceLl.

  • rogerxavier2 rogerxavier2 16 hours ago Flag

    "Welcome to a board that with a few exceptions has a very nice crowd. GL2U&A"
    Thank you.
    In return, my current stance is that there are fundamental perceptual disconnects with what could be and what is concerning Ampion.
    A one site, one investigator(who is also the administering MD.) for 500 potential enrollees for an eight month study is hardly credible.
    For the one investigator, who is also injecting the enrollees not to notice crystallization in the ampules, is hardly credible.

    When the company puts out a letter claiming, "Only one clinical trial site reported any frozen product and that shipment was replaced immediately upon notice." when their total sites are 1, sends up a "Say what?" flag.

    The Dream Team Group, better known for putting lipstick on pigs juggling perceptions, without any prior claim to medical expertise to becoming a valid Contract Research Organization, sends up a "Say What?" flag.

    "31. Michael Macaluso. Defendant Michael Macaluso (“Macaluso”) served as Chief
    Executive Officer (“CEO”) and Director of the Company(Isolagen) from 2001 until his resignation as CEO
    in September 2004, and his subsequent resignation as a director in April 2005. Macaluso also
    served as President of the Company between January 2003 and September 2004. "

    "Defendants' scheme to mislead the investing public concerning Isolagen's chances of obtaining FDA approval of the Isolagen Process and to mass produce its sole product inflated the price of the Company's securities and allowed Isolagen to sell millions of dollars of new securities to investors - even while the Company's executives were dumping their own Isolagen stock at artificially inflated prices."

    A number of those same executives were the original founders of Ampio Pharmaceuticals.

    Who is to say that the current trial isn't expected to have underwhelming results, the principles are aware that the drug does not work and even the hand picked questionable CRO won't be able to adequately massage the numbers?

  • rogerxavier2 rogerxavier2 16 hours ago Flag

    "31. Michael Macaluso. Defendant Michael Macaluso (“Macaluso”) served as Chief
    Executive Officer (“CEO”) and Director of the Company from 2001 until his resignation as CEO
    in September 2004, and his subsequent resignation as a director in April 2005. Macaluso also
    served as President of the Company between January 2003 and September 2004. "

    "36. Jeffrey W. Tomz. Defendant Jeffrey W. Tomz (“Tomz”) served as Isolagen’s
    Chief Financial Officer and Secretary from August 2001 to April 2005. On or about April 19,
    2005, Tomz resigned as the Company’s CFO and was appointed Principal Financial and
    Accounting Officer of Isolagen. In addition, Tomz is a “Principal” at Benchmark Equity Group,
    Inc, a firm wholly owned by Defendant DeLape. "

    Starting to make sense now. Macaluso is one of Ampio's principals.
    jt may actually be pre-informed.

  • rogerxavier2 rogerxavier2 17 hours ago Flag

    "I am buying into the fact that Ampion has treated over a thousand people"
    From a poster staunchly behind the title of this thread I find this statement disturbing.

    Please refer to this study by its ClinicalTrials.gov identifier: NCT02024529
    "Estimated Enrollment:500"

  • rogerxavier2 rogerxavier2 17 hours ago Flag

    "I am buying into the fact that Ampion has treated over a thousand people with no side effects and ROBUST pain reduction, proven fact."

    Proven FACT? Really? How is that you have data which the company is "anxious to view", to quote from their letter?
    "The analysis of the Data has still not been made available to Ampio, although, as can be imagined we are anxious to view it.

  • rogerxavier2 rogerxavier2 17 hours ago Flag

    "We may be in trouble tomorrow after tariffs crushed Trina."
    How did tariffs imposed in Q3 affect Trina's Q2 earnings?
    "The department is expected to confirm the duties on or around August 18. They will then be reviewed by the U.S. International Trade Commission (ITC), with a final decision to be made around October 3."

    TRINA, "Second Quarter 2014 Financial and Operating Highlights

    Solar module shipments were 943.3 MW during the second quarter of 2014, compared to 558.0 MW in the first quarter of 2014, an increase of 69.1%
    Net revenues were $519.4 million, AN INCREASE OF 16.8% from the first quarter of 2014
    Cost of revenues was $439.2 million, AN INCREASE OF 24.3% from the first quarter of 2014
    Gross profit was $80.2 million, A DECREASE OF 12.3% from the first quarter of 2014
    Gross margin was 15.4%, compared to 20.6% in the first quarter of 2014
    Operating income was $15.7 million, a decrease of 59.0% from the first quarter of 2014
    Operating margin was 3.0%, compared to 8.6% in the first quarter of 2014
    Net income was $10.3 million,A DECREASE OF 61.1% from the first quarter of 2014
    Earnings per fully diluted American Depositary Share ("ADS" and each ADS represents 50 of the Company's ordinary shares) was ****$0.14, compared to $0.37***** in the first quarter of 2014'

    Claiming, "Following a relatively weak first quarter in China, we saw strong growth in demand for Trina Solar's products in the second quarter." begs the question be asked whether Trina can be pleased with a 3rd Quarter that exceeds the 2nd Quarter?

  • rogerxavier2 rogerxavier2 18 hours ago Flag

    "To all the new posters, welcome, but be careful with bad data, we don't tolerate it!"
    So you're buying into AMPE's preemptive "frozen drugs made our results worse" nonsense?

  • rogerxavier2 rogerxavier2 18 hours ago Flag

    Here is why I am Not

    " 2nd Quarter Ending June 2014
    Earnings Whisper ®: N/A
    Consensus Estimate: ($0.17)
    Surprise Expectation 1:
    Release Date: [confirmed] 8/27/2014
    Before Open
    Expected Time 2: 7:15 AM ET
    Conference Call: N/A"

    " Expected Quarterly Earnings: (48.5%)
    Expected Quarterly Revenue: 6.8%
    Expected Annual Earnings: (74.5%)
    Expected Annual Revenue: 23.2%
    Previous Annual Earnings: (29.8%)
    Previous Annual Revenue: 21.2% "

    YGE need only meet or slightly exceed any of the expectations and provide positive guidance to soar.

    In the global market for PV USA is a medium to small player. Based on the continuing flurry of signed projects YGE can only provide guidance for increased revenue despite US Tariffs.

  • rogerxavier2 rogerxavier2 18 hours ago Flag

    "Hot and others setting everyone up for another disappointment "

    As you're doing on the AMPE board. Just between us you work for the Dream TEAM Group,don't you?

    Nobody could pick two such obviously fraudulent stocks in a row to pretend to invest in without direction, could they?

  • rogerxavier2 rogerxavier2 20 hours ago Flag

    "Hawtorne shouldn't even go to the Sept 4th conference "

    Why would Hawthorne go? Any flunky can set up and keep and eye on the easel and poster board.
    It's not like UNXL is going to be allowed to waste the time of monied investors.
    Go back to your hole. Isn't it time to start winterizing the tent?

  • rogerxavier2 rogerxavier2 20 hours ago Flag

    "Why is this a trick questions?"
    It's a trick question as the answer is ZERO.

  • Reply to

    In mid 2010 Mr. Seth Klarman purchased

    by dfbcatalano Aug 25, 2014 3:43 PM
    rogerxavier2 rogerxavier2 Aug 25, 2014 5:44 PM Flag

    "Baupost has bought 11 million puts to hedge with today. trust me i know what i'm talking about!!!"

    No.No. you do not.

DMND
27.65-0.02(-0.07%)Aug 26 4:00 PMEDT